Cargando…

Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme

Glioblastoma multiforme (GBM) is the most common type of malignant brain tumor, among which IDH1-wild type GBM has a poor prognosis. Recent studies have shown that ferroptosis-related genes (FRGs) are correlated with the development and progression of cancer. In GBM, the role of FRGs associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xudong, Jin, Shengnan, Shi, Xin, Liu, Shengyu, Li, Kunhang, Liu, Guojun, Zhong, Shiyu, Liu, Tao, Li, Lishuai, Tao, Shanwei, Zhai, Qingqing, Bao, Nan, Ren, Lijie, Wu, Ying, Bao, Yijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095828/ https://www.ncbi.nlm.nih.gov/pubmed/35571123 http://dx.doi.org/10.3389/fphar.2022.898679

Ejemplares similares

Immunotherapeutic Value of MAP1LC3C and Its Candidate FDA-Approved Drugs Identified by Pan-Cancer Analysis, Virtual Screening and Sensitivity Analysis
por: Zhang, Xudong, et al.
Publicado: (2022)

Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022)

Optimal Course of Statins for Patients With Aneurysmal Subarachnoid Hemorrhage: Is Longer Treatment Better? A Meta-Analysis of Randomized Controlled Trials
por: Liu, Tao, et al.
Publicado: (2021)

Risk Factors of Psychological Responses of Chinese University Students During the COVID-19 Outbreak: Cross-sectional Web-Based Survey Study
por: Zhang, Xudong, et al.
Publicado: (2021)

Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
por: Jackson, Christopher, et al.
Publicado: (2011)

Melatonin Modulates the Microenvironment of Glioblastoma Multiforme by Targeting Sirtuin 1
por: Lai, Sheng-Wei, et al.
Publicado: (2019)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

MicroRNA signatures predict prognosis of patients with glioblastoma multiforme through the Cancer Genome Atlas
por: Yuan, Ying, et al.
Publicado: (2017)

Ferroptosis-Related Gene Contributes to Immunity, Stemness and Predicts Prognosis in Glioblastoma Multiforme
por: Dong, Jiawei, et al.
Publicado: (2022)

GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma Multiforme
por: Zimmer, Niklas, et al.
Publicado: (2019)

Immune microenvironments differ in immune characteristics and outcome of glioblastoma multiforme
por: Zhang, Botao, et al.
Publicado: (2019)

Looking for the Holy Grail—Drug Candidates for Glioblastoma Multiforme Chemotherapy
por: Pająk, Beata
Publicado: (2022)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment
por: Jaal, Jana, et al.
Publicado: (2015)

Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment
por: Kumari, Smita, et al.
Publicado: (2023)

Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis
por: Alshabi, Ali Mohamed, et al.
Publicado: (2019)

Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA
por: Yang, Qi, et al.
Publicado: (2018)

Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme
por: Mu, Long, et al.
Publicado: (2022)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Role of Lamin A/C as Candidate Biomarker of Aggressiveness and Tumorigenicity in Glioblastoma Multiforme
por: Gatti, Giuliana, et al.
Publicado: (2021)

Autophagy-dependent ferroptosis as a potential treatment for glioblastoma
por: Xie, Yangchun, et al.
Publicado: (2023)

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme
por: Yang, Liu, et al.
Publicado: (2015)

MRI Manifestions Correlate with Survival of Glioblastoma Multiforme Patients
por: Li, Wen-bin, et al.
Publicado: (2012)

Data Analysis and Tissue Type Assignment for Glioblastoma Multiforme
por: Li, Yuqian, et al.
Publicado: (2014)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

A Ferroptosis-Related Prognostic Risk Score Model to Predict Clinical Significance and Immunogenic Characteristics in Glioblastoma Multiforme
por: Xiao, Dongdong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ob2b5csmrcc10c2bknmheetn2p